Search clinical trials for: SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study

Total 162411 results

GlaxoSmithKline

Completed

Use Of SB-705498 In The Acute Treatment Of Migraine

Migraine, Acute

Australia, Netherlands, United Kingdom, Canada
GlaxoSmithKline

Terminated

Sb-705498 Rectal Pain Study

Irritable Colon

United Kingdom
GlaxoSmithKline

Completed

SB-705498 Dental Pain Study After Tooth Extraction

Toothache

United Kingdom, Italy, Korea, Republic of
GlaxoSmithKline

Completed

SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis

Rhinitis

Canada
GlaxoSmithKline

Completed

Intranasal SB-705498 in Healthy Volunteers

Rhinitis

United Kingdom
GlaxoSmithKline

Completed

A Study to Investigate the Effect of SB-705498 on Chronic Cough

Rhinitis

United Kingdom
GlaxoSmithKline

Completed

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

Rhinitis

Netherlands
GlaxoSmithKline

Completed

Intranasal SB-705498 in Non-allergic Rhinitis Patients

Rhinitis

Netherlands
GlaxoSmithKline

Completed

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Rhinitis

Austria
Lu Yuan Lee
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Expressions of TRPV1 in Airway of Asthmatics (TRPV1)

Pulmonary Atelectasis | Severe Persistent Asthma | Moderate Persistent Asthma | Nodule Solitary Pulmonary

United States
GlaxoSmithKline

Completed

A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

Inflammation | Arthritis, Rheumatoid

United Kingdom
University of Minnesota

Recruiting

Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

Cardiovascular Diseases | Type 2 Diabetes

United States
Kenneth Hargreaves
U.S. Army Medical Research and Development Command; San Antonio Military Medical...

Withdrawn

Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent

Pain | Burns | Hyperalgesia | Thermal Injury

United States
Sylentis, S.A.

Completed

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

Ocular Pain | Dry Eye Syndrome

Spain
Hospices Civils de Lyon

Completed

Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis (MicroPso)

Psoriasis

France
GlaxoSmithKline

Completed

Investigation of Topical SB705498 on Healthy Volunteers

Dermatitis, Atopic

United Kingdom
GlaxoSmithKline

Completed

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Lymphoma | Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

Integrated Biomarker And Imaging Study - 2

Atherosclerosis

Netherlands, Belgium, Germany, Czechia, France, Austria, Spain, Norway, Poland, Denmark, Switzerland
SB Technology, Inc.

Recruiting

MCG Discovery Study in Emergency Departments

NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

United States
GlaxoSmithKline

Completed

Repeat Dose Study in Male Healthy Volunteer Smokers

Pulmonary Disease, Chronic Obstructive

United Kingdom
Universidad Autonoma de San Luis Potosí
Hospital Central "Dr. Ignacio Morones Prieto"

Unknown

TRPV Expression in Subjects With Sensitive Skin

Sensitive Skin

Mexico
GlaxoSmithKline

Completed

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Alzheimer's Disease

Spain, Bulgaria, Korea, Republic of, Chile, Greece, Slovakia, South Africa, New Zealand, Russian Federation, Czech Republic, Austria, Poland, Croatia
Samsung Bioepis Co., Ltd.

Recruiting

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Stage IV

Georgia, India, Romania, Spain
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

Psoriasis | Moderate to Severe Plaque Psoriasis

Czechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
McMaster University
BioGaia AB

Completed

Probiotics and Capsaicin Evoked Coughs (PCEC)

Atopic Asthma

Canada
Medical College of Wisconsin

Completed

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain (TRPV1)

Esophagitis | Gastrointestinal Symptoms | Epigastric Pain | Retrosternal Pain

United States
Case Comprehensive Cancer Center

Active, not recruiting

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditions

United States
GlaxoSmithKline

Completed

A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

Schizophrenia

United Kingdom
GlaxoSmithKline

Completed

A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

Atherosclerosis

United States
Hospital de Mataró
Instituto de Salud Carlos III; Consorci Sanitari del Maresme

Recruiting

Treatment of Chronic Post-stroke Oropharyngeal Dysphagia With Paired Stimulation (ICI20/00117)

Stroke | Oropharyngeal Dysphagia | Swallowing Disorder | Stroke, Complication

Spain
GlaxoSmithKline

Completed

Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

Pulmonary Disease, Chronic Obstructive

Germany
Istituti Clinici Scientifici Maugeri SpA

Recruiting

Psychological Symptoms in Cardiac and Pulmonary Diseases

Depression | Cardiovascular Diseases | Anxiety | Rehabilitation | Psychological Distress | Pulmonary Disease | Coping Behavior

Italy
GlaxoSmithKline

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Sleep Disorders

Germany
GlaxoSmithKline

Completed

SB-743921 In Patients With Solid Tumors

Solid Tumor Cancer

United States
Samsung Bioepis Co., Ltd.

Recruiting

A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage II

Korea, Republic of, Poland, Spain
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Neovascular Age-related Macular Degeneration

Czechia, Estonia, Hungary, Korea, Republic of, Latvia, Poland, United States, Croatia, Japan, Russian Federation
Samsung Bioepis Co., Ltd.

Completed

A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

Poland
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

Poland
GlaxoSmithKline

Completed

First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050

Diabetes Mellitus, Type 2

United States
Medica Cor Heart Hospital

Unknown

Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS) (SBPS)

Coronary Ostium Stenosis | Myonecrosis

Bulgaria
General and Teaching Hospital Celje

Completed

Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia

Sepsis

Slovenia
Science and Research Centre Koper
University of Trieste; University of Padova; Hospital of Izola; University of Graz

Completed

Post COVID19 Functional and Cognitive Assessments (PostCovidZRS)

Covid19 | Cognitive Decline | Respiratory Disease | Walking, Difficulty

Slovenia
General and Teaching Hospital Celje

Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Covid-19

Slovenia
Novartis Pharmaceuticals

Completed

A Rollover Study to Provide Continued Treatment With Eltrombopag

Thrombocytopaenia

Belgium, Greece, Netherlands, Romania, China, Korea, Republic of, Tunisia, France, Hong Kong, Ireland, Peru, Poland
National Cheng-Kung University Hospital

Terminated

Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation

Chemotherapy-induced Abnormal Thermal Sensation

Taiwan
Sangamo Therapeutics

Active, not recruiting

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (LTFU)

Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II

United States
Medical University of Vienna

Completed

Mechanisms of Human Heat Perception - Involvement of TRPA1, TRPV1 and TRPM3

Pain

Austria
Nguyen Thi Trieu, MD

Completed

Composition for Treating Cirrhosis and Liver Cancer (SB-1121) (SB-1121)

Cirrhosis of the Liver

Vietnam
GlaxoSmithKline

Completed

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Lung Injury, Acute

United States

Search clinical trials for: SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations